Prevalence of metabolic syndrome and obesity-associated hypertension in the racial ethnic minorities of the United States

Current Hypertension Reports

Volumn 16, Issue 7, 2014, Pages

  Falkner, Bonita ^a   Cossrow, Nicole D F H ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Adolescents; Adults; Blood pressure; Children; Diabetes; Insulin resistance; Lipids; Metabolic syndrome; Obesity; Race

Indexed keywords

INSULIN;

ADOLESCENT DISEASE; ADULT DISEASE; AGING; ATHEROSCLEROSIS; AWARENESS; BIRTH WEIGHT; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; DYSLIPIDEMIA; EPIDEMIC; ETHNIC GROUP; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLIC SYNDROME X; MINORITY GROUP; OBESITY; OBESITY ASSOCIATED HYPERTENSION; PREVALENCE; REVIEW; UNITED STATES; COMPLICATION; ETHNOLOGY; PHYSIOLOGY;

BLOOD PRESSURE; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; PREVALENCE; UNITED STATES;

EID: 84901546598     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-014-0449-5     Document Type: Review

References (52)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607. (Pubitemid 19004941)
2. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-23. (Pubitemid 9249478)
3. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981;240:E630-9.
4. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-94.
5. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91:2906-12. (Pubitemid 44271734)
6. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-16. (Pubitemid 35403784)
7. Meigs JB, D'Agostino Sr RB, Wilson PW, et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes. 1997;46:1594-600. (Pubitemid 27411235)
8. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab. 1998;83:2773-6. (Pubitemid 28493774)
9. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53. (Pubitemid 28319935)
10. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-3.
11. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
12. Bloomgarden ZT. Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome. Diabetes Care. 2004;27:824-30. (Pubitemid 38280559)
13. Federation ID. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idforg/webdata/docs/Metabolic-syndrome-definitionpdf 2005.
14. Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr. 2008;152:160-4.
15. Goodman E, Daniels SR, Morrison JA, et al. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr. 2004;145:445-51. (Pubitemid 39345978)
16. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. New Engl J M. 2004;350:2362-74. (Pubitemid 38702847)
17. Bergström E, Hernell O, Persson LA, et al. Insulin resistance syndrome in adolescents. Metabolism. 1996;45:908-14. (Pubitemid 26249761)
18. Young-Hyman D, Schlundt DG, Herman L, et al. Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children. Diabetes Care. 2001;24:1359-64. (Pubitemid 33716421)
19. Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab. 2003;88:1417-27. (Pubitemid 36623349)
20. RB E. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. National Health Statistics Reports 2009;13.
21. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9. (Pubitemid 34251969)
22. •• Beltrán-Sánchez HHM, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult US population 1999-2010. J Am Coll Cardiol. 2013;62:697-703. This study estimated the prevalence of metabolic syndrome in U.S. adults and metabolic syndrome components according to sex and race/ethnic populations. The estimates are based on analysis of serial NHANES data periods from 1999-2000 to 2009-2010. The results of this study depict difference in prevalence by race/ethnic groups.
23. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311:806-14.
24. Reaven GM. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals. Endocrinol Metab Clin North Am. 2005;34:49-62. (Pubitemid 40332502)
25. Ryan AS, Nicklas BJ, Berman DM. Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women. Obes Res. 2002;10:336-44. (Pubitemid 135688243)
26. Arslanian S, Suprasongsin C, Janosky JE. Insulin secretion and sensitivity in black versus white prepubertal healthy children. J Clin Endocrinol Metab. 1997;82:1923-7. (Pubitemid 127495211)
27. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996;45:742-8.
28. Sumner AE, Vega GL, Genovese DJ, et al. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism. 2005;54:902-9. (Pubitemid 40827206)
29. Howard BV, Mayer-Davis EJ, Goff D, et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism. 1998;47:1174-9. (Pubitemid 28469240)
30. Stein E, Kushner H, Gidding S, et al. Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome. Metabolism. 2007;56:954-60. (Pubitemid 46890979)
31. Lopes HF, Morrow JD, Stojiljkovic MP, et al. Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens. 2003;16:331-6. (Pubitemid 36570967)
32. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-36. (Pubitemid 36241019)
33. Lteif AA, Han K, Mather KJ. Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation. 2005;112:32-8. (Pubitemid 40962566)
34. Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821-7. (Pubitemid 36988016)
35. Cook S, Auinger P, Li C, et al. Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr. 2008;152:165-70.
36. Ford ES, Li C, Zhao G, et al. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care. 2008;31:587-9.
37. Campbell KL, Kushner H, Falkner B. Obesity and high blood pressure: A clinical phenotype for the insulin resistance syndrome in African Americans. J Clin Hypertens (Greenwich). 2004;6:364-72.
38. Hanevold C, Waller J, Daniels S, et al. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics. 2004;113:328-33. (Pubitemid 38177084)
39. Brady TM, Fivush B, Flynn JT, et al. Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension. J Pediatr. 2008;152:73-8. 78 e71.
40. McNiece KL, Poffenbarger TS, Turner JL, et al. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150:640-4. 644 e641.
41. Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298:874-9. (Pubitemid 47311293)
42. Falkner B, Gidding SS, Ramirez-Garnica G, et al. The relationship of body mass index and blood pressure in primary care pediatric patients. J Pediatr. 2006;148:195-200. (Pubitemid 43286760)
43. Boyd GS, Koenigsberg J, Falkner B, et al. Effect of obesity and high blood pressure on plasma lipid levels in children and adolescents. Pediatrics. 2005;116:442-6. (Pubitemid 44161472)
44. Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2002;40:441-7.
45. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. New Engl J Med. 1998;338:1650-6. (Pubitemid 28267909)
46. Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003;290:2271-6. (Pubitemid 37430559)
47. •• Rosner B, Cook NR, Daniels S, et al. Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008. Hypertension. 2013;62:247-54. This study examined blood pressure trends in children from serial NHANES data. Analysis of serial NHANES data periods demonstrates a progressive increase in blood pressure in children and adolescents, and the increase is attributable to BMI, waist circumference, and dietary sodium intake.
48. Rosner B, Cook N, Portman R, et al. Blood pressure differences by ethnic group among United States children and adolescents. Hypertension. 2009;54:502-8.
49. Barker DJ, Osmond C, Golding J, et al. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ (Clinical research ed). 1989;298:564-7. (Pubitemid 19072097)
50. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA. 2008;300:2886-97.
51. Li C, Johnson MS, Goran MI. Effects of low birth weight on insulin resistance syndrome in Caucasian and African-American children. Diabetes Care. 2001;24:2035-42. (Pubitemid 33716517)
52. •• Lurbe E, Torro MI, Aguilar F, Redon J. Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at five years of age. Hypertension 2014;63:1326-32. This study investigated perinatal programming in a prospective study that enrolled healthy newborn infants, all products of a normal pregnancy, and followed the infants with serial growth and blood pressure measurements, metabolic assessments at age 5 years. Blood pressure correlated positively with weight at all measurement periods. At age 5 years, the low-birth-weight infants were insulin-resistant, regardless of weight at age 5 years, compared to average-birthweight and large-birth-weight infants.